Erschienen in:
29.01.2020 | EDITORIAL
The complicated business of testing our diagnostic tests!
verfasst von:
Prem Soman, MD, PhD, FRCP (UK), FACC, MASNC, Syed Bukhari, MD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 5/2021
Einloggen, um Zugang zu erhalten
Excerpt
Care providers faced with a patient with chest pain have a number of options for noninvasive testing. They also have the option of “not testing” in patients with a low clinical likelihood of angina and a low-risk profile. A strong scientific basis to justify the use of one test over others is lacking and difficult to procure given the magnitude of the undertaking required. Diagnostic tests are usually compared using metrics of test efficacy (diagnostic accuracy). However, metrics of test effectiveness may be equally relevant, including patient outcome after a test, test effectiveness in the real world, downstream resource utilization, and societal cost. …